Who deserves weight-loss drugs? | David A Kessler

New GLP-1 drugs a class that includes Wegovy and Ozempic have revolutionized our understanding of weight loss, but also illuminated flaws in our healthcare delivery.

Patients struggling with excess weight are caught in a system of bewildering complexity and even potential danger.

Compounders are pushing the limits on marketing their versions as approved products and it’s virtually impossible for the consumer to discern the difference between approved drugs and compounded copies.

David Kessler MD served as commissioner of the FDA under Presidents George HW Bush and Bill Clinton .

Kessler : Our bodies have experienced an insidious decline over the past half-century that has been caused by never-ending consumption of foods that can trigger our brains’ addictive circuits.

It would be better to change our food environment than use drugs to tame those circuits, he says.